For: | Soto M, Sampietro-Colom L, Lasalvia L, Mira A, Jiménez W, Navasa M. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients. World J Gastroenterol 2017; 23(17): 3163-3173 [PMID: 28533673 DOI: 10.3748/wjg.v23.i17.3163] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i17/3163.htm |
Number | Citing Articles |
1 |
Alia Hadefi, Delphine Degré, Eric Trépo, Christophe Moreno. Noninvasive diagnosis in alcohol‐related liver disease. Health Science Reports 2020; 3(1) doi: 10.1002/hsr2.146
|
2 |
Efrat Broide, Adi Eindor-Abarbanel, Timna Naftali, Haim Shirin, Tzippora Shalem, Vered Richter, Shay Matalon, Moshe Leshno. Early Surgery Versus Biologic Therapy in Limited Nonstricturing Ileocecal Crohn’s Disease—A Decision-making Analysis. Inflammatory Bowel Diseases 2020; 26(11): 1648 doi: 10.1093/ibd/izz282
|
3 |
Christophe Moreno, Sebastian Mueller, Gyongyi Szabo. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Journal of Hepatology 2019; 70(2): 273 doi: 10.1016/j.jhep.2018.11.025
|
4 |
Romeo-Gabriel Mihăilă. Liver stiffness in chronic hepatitis C virus infection. Romanian Journal of Internal Medicine 2019; 57(2): 85 doi: 10.2478/rjim-2018-0034
|
5 |
Theresa Hydes, William Gilmore, Nick Sheron, Ian Gilmore. Treating alcohol-related liver disease from a public health perspective. Journal of Hepatology 2019; 70(2): 223 doi: 10.1016/j.jhep.2018.10.036
|
6 |
Archana Ramalingam, Samba Siva Rao Pasupuleti, Bharathnag Nagappa, Shiv Kumar Sarin. Health and economic burden due to alcohol-associated liver diseases in the Union Territory of Delhi: A Markov probabilistic model approach. Indian Journal of Gastroenterology 2022; 41(1): 84 doi: 10.1007/s12664-021-01221-4
|
7 |
Mads Israelsen, Wiramon Rungratanawanich, Maja Thiele, Suthat Liangpunsakul. Non-invasive tests for alcohol-associated liver disease. Hepatology 2024; doi: 10.1097/HEP.0000000000000885
|
8 |
Gaurav Jyani, Shankar Prinja, Atul Ambekar, Pankaj Bahuguna, Rajesh Kumar. Health impact and economic burden of alcohol consumption in India. International Journal of Drug Policy 2019; 69: 34 doi: 10.1016/j.drugpo.2019.04.005
|
9 |
Lars Asphaug, Maja Thiele, Aleksander Krag, Hans Olav Melberg. Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis. Hepatology 2020; 71(6): 2093 doi: 10.1002/hep.30979
|
10 |
Ellen Lyngbeck Jensen, Maja Thiele. Alcohol and Alcohol-related Diseases. 2023; : 773 doi: 10.1007/978-3-031-32483-3_40
|
11 |
Hanzhang Zhu, Yuqiang Shan, Ke Ge, Jun Lu, Wencheng Kong, Changku Jia. Specific Overexpression of Mitofusin-2 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in Mice Model. Human Gene Therapy 2020; 31(1-2): 103 doi: 10.1089/hum.2019.153
|
12 |
Mads Israelsen, Aleksander Krag, Maja Thiele. The Human Gut-Liver-Axis in Health and Disease. 2019; : 3 doi: 10.1007/978-3-319-98890-0_1
|
13 |
Daniel Fuster, Xavier García-Calvo, Paola Zuluaga, Ferran Bolao, Robert Muga. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World Journal of Gastroenterology 2021; 27(23): 3223-3237 doi: 10.3748/wjg.v27.i23.3223
|
14 |
Declan Connoley, Preya Janubhai Patel, Brian Hogan, Sudeep Tanwar, Freya Rhodes, Julie Parkes, Alastair Burt, Jennifer Watkins, William Sievert, William Rosenberg. The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01795-5
|
15 |
D. V. Garbuzenko. Principles of diagnosis and treatment of alcohol-induced liver fibrosis. Meditsinskiy sovet = Medical Council 2022; (7): 104 doi: 10.21518/2079-701X-2022-16-7-104-114
|
16 |
Preya Janubhai Patel, Declan Connoley, Freya Rhodes, Ankur Srivastava, William Rosenberg. A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2020; 57(1): 36 doi: 10.1177/0004563219879962
|
17 |
Marilia Mastrocolla de Almeida Cardoso, Lehana Thabane, Fernando Gomes Romeiro, Giovanni Faria Silva, Juliana Machado-Rugolo, Alan Francisco Fonseca, Wendel Mombaque dos Santos, Juliana Tereza Coneglian de Almeida, Kednapa Thavorn, Jean-Eric Tarride. Economic evaluation of non-invasive liver tests for the diagnosis of liver fibrosis in chronic liver diseases: a systematic review protocol. JBI Evidence Synthesis 2023; doi: 10.11124/JBIES-23-00097
|
18 |
Loretta L. Jophlin, Ashwani K. Singal, Ramon Bataller, Robert J. Wong, Bryan G. Sauer, Norah A. Terrault, Vijay H. Shah. ACG Clinical Guideline: Alcohol-Associated Liver Disease. American Journal of Gastroenterology 2024; 119(1): 30 doi: 10.14309/ajg.0000000000002572
|
19 |
Sheng-Hung Chen, Hsueh-Chou Lai, I-Ping Chiang, Wen-Pang Su, Chia-Hsin Lin, Jung-Ta Kao, Po-Heng Chuang, Wei-Fan Hsu, Hung-Wei Wang, Hung-Yao Chen, Guan-Tarn Huang, Cheng-Yuan Peng, Chen-Hua Liu. Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C. PLOS ONE 2018; 13(1): e0190455 doi: 10.1371/journal.pone.0190455
|
20 |
Pablo Gabriel-Medina, Roser Ferrer-Costa, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, J. M. Pericàs, D. M. Selva, Francisco Rodriguez-Frias. Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care level. Internal and Emergency Medicine 2024; 19(3): 745 doi: 10.1007/s11739-023-03441-2
|
21 |
Annalisa Berzigotti, Emmanouil Tsochatzis, Jerome Boursier, Laurent Castera, Nora Cazzagon, Mireen Friedrich-Rust, Salvatore Petta, Maja Thiele. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. Journal of Hepatology 2021; 75(3): 659 doi: 10.1016/j.jhep.2021.05.025
|
22 |
Alexander Hinkson, Hannah Lally, Hannah Gibson, Rebecca Jones, Ian A. Rowe, Bethany Shinkins, Richard Parker. Meta‐analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases. Alimentary Pharmacology & Therapeutics 2023; 57(7): 750 doi: 10.1111/apt.17385
|